S. Ross

发表

Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).

J. Collins, J. Way, C. Laudeman, 2014, Bioorganic & medicinal chemistry letters.

Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists.

K. Evans, R. Rivero, R. Griffin, 2009, Journal of medicinal chemistry.

α1A- but not α1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism

P. Simpson, R. Papay, D. Perez, 2005 .

The alpha(1B)-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model.

P. Gonzalez-Cabrera, M. Piascik, D. Perez, 2003, Cardiovascular research.

Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy.

D. Morilak, S. Sands, M. Zuscik, 2000, Nature medicine.

Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist.

J. Collins, S. Roller, S. M. Sparks, 2017, Bioorganic & medicinal chemistry letters.

Hypotension, Autonomic Failure, and Cardiac Hypertrophy in Transgenic Mice Overexpressing the α1B-Adrenergic Receptor*

M. Zuscik, M. Piascik, D. Perez, 2001, The Journal of Biological Chemistry.

Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.

D. Rajpal, Chari D Smith, B. Gedulin, 2012, American journal of physiology. Endocrinology and metabolism.

Genetic profiling of alpha 1-adrenergic receptor subtypes by oligonucleotide microarrays: coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130.

P. Gonzalez-Cabrera, R. Papay, D. Perez, 2003, Molecular pharmacology.

Gene expression profiling of alpha(1b)-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays.

P. Gonzalez-Cabrera, M. Zuscik, M. Piascik, 2003, Cardiovascular research.

alpha1A- but not alpha1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism.

P. Simpson, R. Papay, D. Perez, 2005, Cardiovascular research.

Mice expressing the α1B‐adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation

P. Gonzalez-Cabrera, M. Zuscik, R. Papay, 2002, Journal of neurochemistry.

Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy

Scott Sands, D. Morilak, S. Sands, 2000, Nature Medicine.

Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists.

P. Gonzalez-Cabrera, M. Zuscik, D. Perez, 2001, The Journal of biological chemistry.

Phe-308 and Phe-312 in Transmembrane Domain 7 Are Major Sites of α1-Adrenergic Receptor Antagonist Binding

P. Gonzalez-Cabrera, M. Zuscik, D. Perez, 2001, The Journal of Biological Chemistry.

Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.

S. Roller, J. Way, S. Ross, 2012, Journal of medicinal chemistry.

Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.

D. Rajpal, Chari D Smith, B. Gedulin, 2012, American journal of physiology. Endocrinology and metabolism.